| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |